This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
The International Pharmaceutical Expo (Interphex), an annual event focused on pharmaceutical and biotechnology technology, has been rescheduled due to the COVID-19 virus.
Cross contamination in the pharmaceutical industry is not just an issue for those working in it, but for the wider public as a whole. As general awareness of the potential issues has increased, more questions are being asked of manufacturers and health professionals about the safety, integrity and potential side effects of a range of products and medicines.
Oxidizers addressed emissions concerns and brought processes into regulatory compliance in silicone and pharmaceutical processing as well as in a petrochemical facility.
What do a pharmaceutical processor, chemicals facility and silicones converter have in common? Each added oxidizers to address emissions concerns and bring their processes into regulatory compliance.